Physician profile
Thomas P Knecht
NPI 1235371857
$12,310.38
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,558 · 2020: $1,808 · 2021: $1,944.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $6,436.30 | 2019-2021 | |
| Dr.Reddy'S Laboratories,INC. | $724.00 | 2021 | |
| Sanofi-Aventis U.S. LLC | $637.38 | 2019-2021 | |
| Companion Medical, INC. | $520.09 | 2019-2020 | |
| Novo Nordisk INC | $519.53 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $499.61 | 2019-2020 | |
| Amarin Pharma, INC. | $339.68 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $317.72 | 2019-2020 | |
| Amgen INC. | $289.15 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $249.65 | 2019-2020 | |
| Dexcom, INC. | $216.36 | 2019 | |
| Janssen Pharmaceuticals, INC | $198.21 | 2019 | |
| Abbvie INC. | $187.97 | 2019-2020 | |
| Lilly USA, LLC | $167.38 | 2019-2020 | |
| Tandem Diabetes Care, INC. | $164.64 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Senseonics, Incorporated | $161.00 | 2019 | |
| Medtronic Minimed, INC. | $158.97 | 2019-2020 | |
| Abbott Laboratories | $116.83 | 2019-2020 | |
| Radius Health, INC. | $81.53 | 2019-2020 | |
| Eisai INC. | $77.25 | 2019-2020 | |
| Mannkind Corporation | $72.06 | 2019-2020 | |
| Aegerion Pharmaceuticals, INC. | $50.68 | 2019 | |
| Ibsa Pharma INC. | $40.06 | 2020 | |
| Shire North American Group INC | $22.96 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $21.53 | 2019 | |
| Xeris Pharmaceuticals, INC. | $20.25 | 2020 | |
| Sun Pharmaceutical Industries INC. | $19.59 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Knecht listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.